Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Quality of Life Study in Patients With Migraines

This study has been terminated.
(Study terminated due to expiration of IRB approval)
Sponsor:
Collaborators:
Rush University Medical Center
GlaxoSmithKline
Information provided by (Responsible Party):
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00298805
First received: March 1, 2006
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)